340B Drug Pricing Program
Tom Nickels
Executive Vice President
The Government Accountability Office yesterday released a report examining the characteristics of hospitals that participate in the 340B drug savings program and hospitals that do not participate in the program.
The AHA, Association of American Medical Colleges and America’s Essential Hospitals today said they expect to “refile promptly in district court” their lawsuit challenging a nearly 30% Medicare payment reduction for many hospitals in the 340B drug savings program.
WASHINGTON, DC (July 17, 2018) – Today, the American Hospital Association (AHA), the Association of American Medical Colleges (AAMC), and America’s Essential Hospitals released the following statement:
AMERICAN HOSPITAL ASSOCIATION, ET AL., APPELLANTS v. ALEX MICHAEL AZAR II, IN HIS OFFICIAL CAPACITY AS THE SECRETARY OF HEALTH AND HUMAN SERVICES AND UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES, APPELLEES
Appeal from the United States District Court for the District of Columbia (No. 1:17…
The AHA today submitted comments on the Department of Health and Human Services’ blueprint to lower drug prices and out-of-pocket costs.
AHA comments on the 340B section of the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
The House Energy and Commerce Subcommittee on Health today hosted a hearing focused on the 340B drug savings program, including examining more than a dozen legislative proposals that would make changes to the program.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, including more than 1,900 hospitals that participate in the 340B drug savings program, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other…
The 340B drug savings program must be reformed, Health and Human Services Secretary Alex Azar said today at a 340B conference in Washington, D.C.